Critical Care Medicine Service, Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
JCO Oncol Pract. 2023 Jun;19(6):e838-e847. doi: 10.1200/OP.22.00395. Epub 2023 Feb 21.
Although delirium is known to negatively affect critically ill patients, little data exist on delirium in critically ill patients with cancer.
We analyzed 915 critically ill patients with cancer between January and December 2018. Delirium screening was performed using the Confusion Assessment Method for the intensive care unit (ICU), performed twice daily. Confusion Assessment Method-ICU incorporates four features of delirium: acute fluctuations in mental status, inattention, disorganized thinking, and altered levels of consciousness. Multivariable analysis controlling for admitting service, pre-ICU hospital length of stay (LOS), metastatic disease, CNS involvement, Mortality Probability Model II score on ICU admission, mechanical ventilation, and others was performed to determine precipitating factors for delirium, ICU, and hospital mortality and LOS.
Delirium occurred in 40.5% (n = 317) of patients; 43.8% (n = 401) were female; the median age was 64.9 (interquartile range, 54.6-73.2) years; 70.8% (n = 647) were White, 9.3% (n = 85) were Black, and 8.9% (n = 81) were Asian. The most common cancer types were hematologic (25.7%, n = 244) and gastrointestinal (20.9%, n = 191). Delirium was independently associated with age (OR, 1.01; 95% CI, 1.00 to 1.02; = .038), longer pre-ICU hospital LOS (OR, 1.04; 95% CI, 1.02 to 1.06; < .001), not resuscitating on admission (OR, 2.18; 95% CI, 1.07 to 4.44; = .032), CNS involvement (OR, 2.25; 95% CI, 1.20 to 4.20; = .011), higher Mortality Probability Model II score (OR, 1.02; 95% CI, 1.01 to 1.02; < .001), mechanical ventilation (OR, 2.67; 95% CI, 1.84 to 3.87; < .001), and sepsis diagnosis (OR, 0.65; 95% CI, 0.43 to 0.99; = .046). Delirium was also independently associated with higher ICU mortality (OR, 10.75; 95% CI, 5.91 to 19.55; < .001), hospital mortality (OR, 5.84; 95% CI, 4.03 to 8.46; < .001), and ICU LOS (estimate, 1.67; 95% CI, 1.54 to 1.81; < .001).
Delirium significantly worsens outcome in critically ill patients with cancer. Delirium screening and management should be integrated into the care of this patient subgroup.
虽然谵妄已知会对重症患者产生负面影响,但关于癌症重症患者谵妄的数据却很少。
我们分析了 2018 年 1 月至 12 月期间的 915 名癌症重症患者。使用重症监护病房(ICU)的意识混乱评估方法(Confusion Assessment Method for the intensive care unit,CAM-ICU)进行谵妄筛查,每天筛查两次。CAM-ICU 包含谵妄的四个特征:精神状态的急性波动、注意力不集中、思维混乱和意识水平改变。采用多变量分析控制入院科室、入 ICU 前医院住院时间(LOS)、转移性疾病、中枢神经系统受累、入 ICU 时的死亡率预测模型 II 评分、机械通气等因素,以确定谵妄、ICU 和医院死亡率以及 LOS 的诱发因素。
40.5%(n=317)的患者发生了谵妄;43.8%(n=401)为女性;中位年龄为 64.9(四分位间距,54.6-73.2)岁;70.8%(n=647)为白人,9.3%(n=85)为黑人,8.9%(n=81)为亚裔。最常见的癌症类型为血液系统(25.7%,n=244)和胃肠道(20.9%,n=191)。谵妄与年龄(OR,1.01;95%CI,1.00 至 1.02;=0.038)、入 ICU 前医院 LOS 较长(OR,1.04;95%CI,1.02 至 1.06;<0.001)、入院时不复苏(OR,2.18;95%CI,1.07 至 4.44;=0.032)、中枢神经系统受累(OR,2.25;95%CI,1.20 至 4.20;=0.011)、死亡率预测模型 II 评分较高(OR,1.02;95%CI,1.01 至 1.02;<0.001)、机械通气(OR,2.67;95%CI,1.84 至 3.87;<0.001)和脓毒症诊断(OR,0.65;95%CI,0.43 至 0.99;=0.046)独立相关。谵妄也与 ICU 死亡率(OR,10.75;95%CI,5.91 至 19.55;<0.001)、医院死亡率(OR,5.84;95%CI,4.03 至 8.46;<0.001)和 ICU LOS(估计值,1.67;95%CI,1.54 至 1.81;<0.001)显著相关。
谵妄显著恶化了癌症重症患者的预后。应将谵妄筛查和管理纳入这一亚组患者的治疗中。